LAS VEGAS, NV / ACCESSWIRE / November 24, 2020 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, just announced the limited-edition collaboration between its branded division, City Trees, and State Flower, a renowned cannabis cultivator with distribution and cultivation operations in San Francisco and Las Vegas.
The two sustainability-minded brands make a perfect pair for this collaborative project. With City Trees' commitment to recyclable packaging and environmental stewardship and State Flower's complementary ethos, featuring Environcann certified cultivation practices, the two companies have come together to produce a concentrate that is both mindful of the planet and of the highest quality.
The selected strain, Wedding Cake, was chosen for this collaboration for its longstanding popularity across multiple markets. Further, the robust resin production of this strain creates higher yields during the extraction process, and the distinct strains crossed to produce this cultivar create a full-bodied, unique aroma and terpene profile that is highly desirable in the cannabis industry. This collaboration project represents the first live resin - produced from fresh plant material rather than dried and cured material - interpretation of this highly sought after strain as presented by State Flower.
Through a carefully curated Vendor Qualification process, City Trees and State Flower elected to collaborate in a joint effort to represent the unique expertise presented by both organizations, while embracing their shared focus on sustainability and quality. Combining forces offered an opportunity for both organizations to showcase the best of what they offer in one product. This collaboration represents the first co-branded offering from City Trees as it looks to expand and refine its concentrate division - a category in which City Trees has seen over 115% growth in unit sales year-over-year through September 2020.
While this project is the first fully co-branded concentrate released from the City Trees laboratory, the brand has now produced extraction products in coordination with multiple renowned cultivators in the Nevada cannabis market through its toll processing services. CLS, through its City Trees division, continues to forge strong partnerships with its peers in pursuit of its mission to produce the highest quality, cleanest extraction products available in the cannabis industry.
About CLS Holdings USA, Inc.
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. https://www.clsholdingsinc.com/.Twitter: @CLSHoldingsUSA
About City Trees
Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada. https://citytrees.com
Forward Looking Statements
This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements''). These statements relate to, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the effect of our initiatives to expand market share and achieve growth during and following the pandemic, the potency and desirability of certain of our offered strains, results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material. In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.
Contact Information:
Corporate:
Chairman and CEO
Jeff Binder
President and COO
Andrew Glashow
888-438-9132
Investor Relations:
[email protected]
SOURCE: CLS Holdings USA, Inc.